Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Other Operating Expenses (2016)

Historic Other Operating Expenses for Pharma (IGC) over the last 4 years, with Q4 2016 value amounting to -$111960.0.

  • Pharma's Other Operating Expenses rose 8360.59% to -$111960.0 in Q4 2016 from the same period last year, while for Sep 2017 it was -$111960.0, marking a year-over-year increase of 9620.24%. This contributed to the annual value of -$3.0 million for FY2016, which is 3587.7% up from last year.
  • Latest data reveals that Pharma reported Other Operating Expenses of -$111960.0 as of Q4 2016, which was up 8360.59% from -$614474.0 recorded in Q3 2016.
  • Pharma's 5-year Other Operating Expenses high stood at -$111960.0 for Q4 2016, and its period low was -$1.9 million during Q1 2015.
  • For the 3-year period, Pharma's Other Operating Expenses averaged around -$788774.8, with its median value being -$623403.0 (2015).
  • In the last 5 years, Pharma's Other Operating Expenses tumbled by 1500.11% in 2015 and then surged by 8360.59% in 2016.
  • Pharma's Other Operating Expenses (Quarter) stood at -$593845.0 in 2014, then fell by 15.0% to -$682928.0 in 2015, then soared by 83.61% to -$111960.0 in 2016.
  • Its last three reported values are -$111960.0 in Q4 2016, -$614474.0 for Q3 2016, and -$383566.0 during Q2 2016.